JP2017530092A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017530092A5 JP2017530092A5 JP2017504375A JP2017504375A JP2017530092A5 JP 2017530092 A5 JP2017530092 A5 JP 2017530092A5 JP 2017504375 A JP2017504375 A JP 2017504375A JP 2017504375 A JP2017504375 A JP 2017504375A JP 2017530092 A5 JP2017530092 A5 JP 2017530092A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- molecule
- antibody molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 14
- 239000002260 anti-inflammatory agent Substances 0.000 claims 6
- 230000003115 biocidal effect Effects 0.000 claims 6
- 231100000433 cytotoxic Toxicity 0.000 claims 6
- 230000001472 cytotoxic effect Effects 0.000 claims 6
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 5
- 108010047041 Complementarity Determining Regions Proteins 0.000 claims 4
- 230000002285 radioactive effect Effects 0.000 claims 3
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 229940124599 anti-inflammatory drug Drugs 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1413357.3 | 2014-07-28 | ||
| GBGB1413357.3A GB201413357D0 (en) | 2014-07-28 | 2014-07-28 | Antibodies for treatment and diagnosis |
| PCT/EP2015/067314 WO2016016269A1 (en) | 2014-07-28 | 2015-07-28 | Anti-collagen antibodies for treatment and diagnosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017530092A JP2017530092A (ja) | 2017-10-12 |
| JP2017530092A5 true JP2017530092A5 (cg-RX-API-DMAC7.html) | 2019-04-18 |
| JP6577016B2 JP6577016B2 (ja) | 2019-09-18 |
Family
ID=51587356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017504376A Pending JP2017526654A (ja) | 2014-07-28 | 2015-07-28 | 治療及び診断のための抗体 |
| JP2017504375A Expired - Fee Related JP6577016B2 (ja) | 2014-07-28 | 2015-07-28 | 治療及び診断のための抗コラーゲン抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017504376A Pending JP2017526654A (ja) | 2014-07-28 | 2015-07-28 | 治療及び診断のための抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US10125190B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3174900A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2017526654A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2992136C (cg-RX-API-DMAC7.html) |
| GB (1) | GB201413357D0 (cg-RX-API-DMAC7.html) |
| WO (2) | WO2016016265A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019005947A (es) | 2016-11-28 | 2019-08-26 | Chugai Pharmaceutical Co Ltd | Molecula de union a ligando que tiene actividad de union a ligando ajustable. |
| AU2017364817B2 (en) | 2016-11-28 | 2023-11-09 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding domain, and polypeptide including conveying section |
| AU2017375460A1 (en) * | 2016-12-15 | 2019-07-04 | The Brigham And Women's Hospital, Inc. | Tissue-based biologics for the treatment of inflammatory and autoimmune disorders |
| GB201621806D0 (en) | 2016-12-21 | 2017-02-01 | Philogen Spa | Immunocytokines with progressive activation mechanism |
| JP2020508319A (ja) * | 2017-02-24 | 2020-03-19 | フィロジェン ソチエタ ペル アツィオーニ | 最適化されたリンカーおよび方向性を有する免疫複合体 |
| WO2019094938A2 (en) | 2017-11-13 | 2019-05-16 | The University Of Chicago | Methods and compositions for the treatment of wounds |
| KR20200089312A (ko) | 2017-11-28 | 2020-07-24 | 추가이 세이야쿠 가부시키가이샤 | 리간드 결합 활성을 조정 가능한 리간드 결합 분자 |
| KR20250134208A (ko) | 2017-11-28 | 2025-09-09 | 추가이 세이야쿠 가부시키가이샤 | 항원 결합 도메인 및 운반 부분을 포함하는 폴리펩티드 |
| WO2019183131A1 (en) | 2018-03-19 | 2019-09-26 | Bioventures, Llc | Periostin antibodies and methods of using the same |
| CA3095134A1 (en) | 2018-03-28 | 2019-10-03 | Board Of Regents, The University Of Texas System | Identification of epigenetic alterations in dna isolated from exosomes |
| WO2019230867A1 (en) * | 2018-05-30 | 2019-12-05 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide comprising aggrecan binding domain and carrying moiety |
| CN112384532B (zh) * | 2018-06-29 | 2025-01-10 | 艾利妥 | 抗SIRP-β1抗体及其使用方法 |
| JP2022536982A (ja) * | 2019-06-21 | 2022-08-22 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | 癌およびその他の疾患の処置のためのα３β１インテグリンの標的化 |
| BR112022001985A2 (pt) * | 2019-09-11 | 2022-05-10 | Boehringer Ingelheim Io Canada Inc | Métodos para tratamento de câncer pelo uso de inibidores do eixo pd-1 e anticorpos anti-periostina |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5541295A (en) * | 1993-02-12 | 1996-07-30 | The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations | Detection of type II collagen and its peptides |
| WO2000040597A1 (en) * | 1999-01-06 | 2000-07-13 | University Of Southern California | Method and composition for angiogenesis inhibition |
| EP1423135A4 (en) * | 2001-08-06 | 2006-06-07 | Univ California | METHODS OF INHIBITING ANGIOGENESIS |
| GB0207224D0 (en) * | 2002-03-27 | 2002-05-08 | Novartis Forschungsstiftung | Tenascin-W compositions and uses thereof |
| GB0708585D0 (en) * | 2007-05-03 | 2007-06-13 | Queen Mary & Westfield College | Novel antibody and use in diagnosis and therapy of arthropathies |
| US20120237948A1 (en) * | 2009-09-16 | 2012-09-20 | Shionogi & Co., Ltd. | Collagen neoepitope antibody |
| EP3050899B1 (en) | 2010-09-27 | 2019-09-04 | Janssen Biotech, Inc. | Antibodies binding human collagen ii |
-
2014
- 2014-07-28 GB GBGB1413357.3A patent/GB201413357D0/en not_active Ceased
-
2015
- 2015-07-28 US US15/329,222 patent/US10125190B2/en not_active Expired - Fee Related
- 2015-07-28 JP JP2017504376A patent/JP2017526654A/ja active Pending
- 2015-07-28 WO PCT/EP2015/067309 patent/WO2016016265A1/en not_active Ceased
- 2015-07-28 EP EP15744198.1A patent/EP3174900A1/en not_active Withdrawn
- 2015-07-28 WO PCT/EP2015/067314 patent/WO2016016269A1/en not_active Ceased
- 2015-07-28 CA CA2992136A patent/CA2992136C/en not_active Expired - Fee Related
- 2015-07-28 JP JP2017504375A patent/JP6577016B2/ja not_active Expired - Fee Related
- 2015-07-28 EP EP15744195.7A patent/EP3174899A1/en not_active Withdrawn
- 2015-07-28 US US15/329,223 patent/US10098976B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017530092A5 (cg-RX-API-DMAC7.html) | ||
| JP2013121353A5 (cg-RX-API-DMAC7.html) | ||
| HRP20201975T1 (hr) | Neutralizirajuća protutijela anti-influenca a virusa i njihova uporaba | |
| HRP20200882T1 (hr) | Vezujuće molekule specifične za asct2 i njihova uporaba | |
| FI3487882T3 (fi) | Gprc5d-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat gprc5d:tä ja cd3:a, sekä niiden käyttötapoja | |
| JP2010534237A5 (cg-RX-API-DMAC7.html) | ||
| NZ602040A (en) | Anti-lrp6 antibodies | |
| JP2010523541A5 (cg-RX-API-DMAC7.html) | ||
| JP2011502137A5 (cg-RX-API-DMAC7.html) | ||
| HRP20180352T1 (hr) | Protutijela anti-fcrh5 | |
| HRP20201022T1 (hr) | Potpuno ljudsko antitijelo protiv ljudskog cd137 i njegova uporaba | |
| HRP20191678T1 (hr) | Pd-1 protutijelo, njegov fragment koji se veže na antigen, i njegova medicinska primjena | |
| HRP20231578T1 (hr) | Molekule protutijela na april i njihove uporabe | |
| HRP20201064T1 (hr) | Postupci liječenja tauopatije | |
| HRP20221088T1 (hr) | Protutijela i postupci uporabe | |
| PE20150025A1 (es) | Anticuerpos e inmunoconjugados contra ly6e y metodos de uso | |
| JP2017535257A5 (cg-RX-API-DMAC7.html) | ||
| HRP20211444T1 (hr) | Anti-dll3 antitijelo | |
| JP2016135783A5 (cg-RX-API-DMAC7.html) | ||
| HRP20180015T1 (hr) | Anti-mezotelinski imunokonjugati i njihova uporaba | |
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| PE20150211A1 (es) | Anticuerpos e inmunoconjugados anti-cd79b | |
| EA201391159A1 (ru) | Hla-рестриктированные пептидоспецифические антигенсвязывающие белки | |
| JP2012010714A5 (cg-RX-API-DMAC7.html) | ||
| RU2017114968A (ru) | Связывающие молекулы, а именно антитела, способные связываться с l1cam (cd171) |